• Vanda Settles HETLIOZ Patent Litigation With MSN

    来源: NASDAQ US Markets / 14 1月 2022 09:53:16   America/New_York

    (RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) said that it has reached a License Agreement with MSN Pharmaceuticals Inc., MSN Laboratories Private Limited and Impax Laboratories to settle Vanda's patent litigation against MSN regarding MSN's Abbreviated New Drug Application seeki https://www.nasdaq.com/articles/vanda-settles-hetlioz-patent-litigation-with-msn
分享